Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02565758
Title ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Cancer Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

Advanced Solid Tumor

Therapies

Gemcitabine

Nivolumab

Nab-paclitaxel

ABBV-085

Age Groups: adult
Covered Countries USA | FRA | ESP


No variant requirements are available.